Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety

Abstract Background To observe the medium- and long-term clinical efficacy and safety of radioactive 125I seed implantation for refractory malignant tumours based on CT-guided 3D template-assisted technique. Methods Twenty-five patients with refractory malignant tumours who underwent radioactive 125...

Full description

Bibliographic Details
Main Authors: Guang Sheng Zhao, Song Liu, Liang Yang, Chuang Li, Ruo Yu Wang, Jun Zhou, Yue Wei Zhang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-020-07223-3
_version_ 1818541929399320576
author Guang Sheng Zhao
Song Liu
Liang Yang
Chuang Li
Ruo Yu Wang
Jun Zhou
Yue Wei Zhang
author_facet Guang Sheng Zhao
Song Liu
Liang Yang
Chuang Li
Ruo Yu Wang
Jun Zhou
Yue Wei Zhang
author_sort Guang Sheng Zhao
collection DOAJ
description Abstract Background To observe the medium- and long-term clinical efficacy and safety of radioactive 125I seed implantation for refractory malignant tumours based on CT-guided 3D template-assisted technique. Methods Twenty-five patients with refractory malignant tumours who underwent radioactive 125I seed implantation based on CT-guided 3D template-assisted technique were selected. The post-operative adverse reactions were recorded. The number of puncture needles and particles used in the operation, dosimetric parameters, post-operative physical strength scores, and tumour response were statistically analysed. The overall survival time and survival rate were calculated, and the effect and prognosis were assessed. Results 125I seed implantation was successful in all patients without serious complications. The average number of implanted puncture needles was 17 (19.12 ± 13.00), and the median number of particles was 52 (55.12 ± 32.97). D90 in the post-operative clinical target volume (CTV) (93.24 ± 15.70 Gy) was slightly lower than that in the pre-operative CTV (93.92 ± 17.60 Gy; P > 0.05). The D90 in the post-operative planning target volume (PTV) (142.16 ± 22.25 Gy) was lower than the pre-operative PTV (145.32 ± 23.48 Gy; P > 0.05). The tumour responses at 6 months post-operatively: complete remission (CR), 20% (5/25); partial remission (PR), 48% (12/25); stable disease (SD), 24% (6/25); progressive disease (PD), 8% (2/25); CR + PR, 68% (17/25); and local control rate, 92% (23/25). The 6-, 12-, and 24-month survival rates were 100, 88, and 52%, respectively. The post-operative physical strength score (Karnofsky performance score, KPS) exhibited a gradual trend towards recovery, which rose to the highest value 12 months after implantation and then decreased slightly, but the average score was still > 90 points. There was one intra-operative pneumothorax, and two patients with superficial malignant tumours developed skin ulcerations. Multivariate analysis of prognosis showed that tumour sites and types were independent risk factors affecting survival. The number of needles and particles and template types were not the factors. Conclusions 3D template combined with CT-guided radioactive 125I seed implantation can improve the rational distribution of radiation dose in the tumour target area because accurate radioactive 125I particle implantation was achieved. This technique has fewer complications and can further extend the overall survival and improve the quality of life. Trial registration Registration number: ChiCTR2000034566 2020/7/10 0:00:00 Retrospectively registered.
first_indexed 2024-12-11T22:15:33Z
format Article
id doaj.art-9a9299e965084a53807f16b1b8906007
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T22:15:33Z
publishDate 2020-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-9a9299e965084a53807f16b1b89060072022-12-22T00:48:37ZengBMCBMC Cancer1471-24072020-08-012011910.1186/s12885-020-07223-3Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safetyGuang Sheng Zhao0Song Liu1Liang Yang2Chuang Li3Ruo Yu Wang4Jun Zhou5Yue Wei Zhang6Tumor Center, Affiliated Zhongshan Hospital of Dalian UniversityLinyi Cancer HospitalAffiliated Zhongshan Hospital of Dalian UniversityAffiliated Zhongshan Hospital of Dalian UniversityAffiliated Zhongshan Hospital of Dalian UniversityAffiliated Zhongshan Hospital of Dalian UniversityHepatobiliary and Pancreatic Center, Beijing Tsinghua Changgung HospitalAbstract Background To observe the medium- and long-term clinical efficacy and safety of radioactive 125I seed implantation for refractory malignant tumours based on CT-guided 3D template-assisted technique. Methods Twenty-five patients with refractory malignant tumours who underwent radioactive 125I seed implantation based on CT-guided 3D template-assisted technique were selected. The post-operative adverse reactions were recorded. The number of puncture needles and particles used in the operation, dosimetric parameters, post-operative physical strength scores, and tumour response were statistically analysed. The overall survival time and survival rate were calculated, and the effect and prognosis were assessed. Results 125I seed implantation was successful in all patients without serious complications. The average number of implanted puncture needles was 17 (19.12 ± 13.00), and the median number of particles was 52 (55.12 ± 32.97). D90 in the post-operative clinical target volume (CTV) (93.24 ± 15.70 Gy) was slightly lower than that in the pre-operative CTV (93.92 ± 17.60 Gy; P > 0.05). The D90 in the post-operative planning target volume (PTV) (142.16 ± 22.25 Gy) was lower than the pre-operative PTV (145.32 ± 23.48 Gy; P > 0.05). The tumour responses at 6 months post-operatively: complete remission (CR), 20% (5/25); partial remission (PR), 48% (12/25); stable disease (SD), 24% (6/25); progressive disease (PD), 8% (2/25); CR + PR, 68% (17/25); and local control rate, 92% (23/25). The 6-, 12-, and 24-month survival rates were 100, 88, and 52%, respectively. The post-operative physical strength score (Karnofsky performance score, KPS) exhibited a gradual trend towards recovery, which rose to the highest value 12 months after implantation and then decreased slightly, but the average score was still > 90 points. There was one intra-operative pneumothorax, and two patients with superficial malignant tumours developed skin ulcerations. Multivariate analysis of prognosis showed that tumour sites and types were independent risk factors affecting survival. The number of needles and particles and template types were not the factors. Conclusions 3D template combined with CT-guided radioactive 125I seed implantation can improve the rational distribution of radiation dose in the tumour target area because accurate radioactive 125I particle implantation was achieved. This technique has fewer complications and can further extend the overall survival and improve the quality of life. Trial registration Registration number: ChiCTR2000034566 2020/7/10 0:00:00 Retrospectively registered.http://link.springer.com/article/10.1186/s12885-020-07223-3125I seedRefractory malignant tumours3D templateEfficacySafety
spellingShingle Guang Sheng Zhao
Song Liu
Liang Yang
Chuang Li
Ruo Yu Wang
Jun Zhou
Yue Wei Zhang
Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
BMC Cancer
125I seed
Refractory malignant tumours
3D template
Efficacy
Safety
title Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
title_full Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
title_fullStr Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
title_full_unstemmed Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
title_short Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety
title_sort evaluation of radioactive 125i seed implantation for the treatment of refractory malignant tumours based on a ct guided 3d template assisted technique efficacy and safety
topic 125I seed
Refractory malignant tumours
3D template
Efficacy
Safety
url http://link.springer.com/article/10.1186/s12885-020-07223-3
work_keys_str_mv AT guangshengzhao evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT songliu evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT liangyang evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT chuangli evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT ruoyuwang evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT junzhou evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety
AT yueweizhang evaluationofradioactive125iseedimplantationforthetreatmentofrefractorymalignanttumoursbasedonactguided3dtemplateassistedtechniqueefficacyandsafety